Marshall Wace North America’s Option Care Health OPCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$47M Buy
1,936,039
+407,605
+27% +$9.45M 0.2% 105
2021
Q2
$33.4M Sell
1,528,434
-744,427
-33% -$14.3M 0.14% 153
2021
Q1
$40.3M Buy
2,272,861
+1,060,540
+87% +$19.9M 0.17% 144
2020
Q4
$19M Sell
1,212,321
-312,144
-20% -$4.64M 0.09% 265
2020
Q3
$20.4M Buy
+1,524,465
New +$18.5M 0.13% 186
2019
Q1
Sell
-9,897
Closed -$141K 1804
2018
Q4
$141K Buy
+9,897
New +$131K ﹤0.01% 1021
2018
Q2
Sell
-3,548
Closed -$35K 1607
2018
Q1
$35K Buy
+3,548
New +$41K ﹤0.01% 1388
2017
Q4
Sell
-14,732
Closed -$177K 1544
2017
Q3
$177K Buy
+14,732
New +$166K ﹤0.01% 1186
2013
Q3
Sell
-2,552
Closed -$168K 679
2013
Q2
$168K Buy
+2,552
New +$143K 0.01% 402

Other funds holding OPCH

Marshall Wace North America's OPCH Position: Q3 2021 in Review

Marshall Wace North America increased its Option Care Health (OPCH) stake by 27% in Q3 2021, buying an estimated $9.45M and bringing the position to 1,936,039 shares worth $47M. The position accounts for 0.2% of the portfolio, ranked #105.

Marshall Wace North America first reported a position in OPCH in Q2 2013 and has held it in 9 quarters since. 210 funds tracked by Wall St. Rank hold OPCH as of Q3 2021.

  • Marshall Wace North America held 1,936,039 shares of Option Care Health worth $47M as of Q3 2021.
  • Marshall Wace North America bought 407,605 Option Care Health shares in Q3 2021, an estimated $9.45M.
  • Option Care Health made up 0.2% of Marshall Wace North America's portfolio in Q3 2021, its #105 holding.
  • Marshall Wace North America first reported a position in Option Care Health in Q2 2013 and has held it in 9 quarters since.
  • 210 funds tracked by Wall St. Rank held Option Care Health as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.